Palvella Therapeutics Inc (PVLA)
R&D Expenses
$35.46M
TTM · Period ending: · USD
PVLA R&D Expenses
Latest reported$35.46Mperiod ending
Latest reported$35.46Mperiod ending
PVLA R&D Expenses ($64.20M → $35.46M)
Annual R&D Expenses
High-resolution chart · PNG
PVLA r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 22,841,000 | |
| 8,151,000 | |
| 8,793,000 | |
| 50,212,000 | |
| 64,197,000 |